Table 1.
Demographics characteristics of baseline study populations
| Characteristics | Overall n (%) | BB n (%) | IVM n (%) | P-value |
|---|---|---|---|---|
| All participants | 760 (100.0) | 435 (57.2) | 325 (42.8) | – |
| Sex | ||||
| Male | 353 (46.4) | 194 (44.6) | 159 (48.9) | 0.257 |
| Female | 407 (53.6) | 241 (55.4) | 166 (51.1) | |
| Ethnicity | ||||
| Fijian | 524 (98.5) | 278 (97.5) | 246 (99.6) | 0.053b |
| Othersa | 8 (1.5) | 7 (2.5) | 1 (<1) | |
| Median age (IQR) | 16 (8–43) | 16 (8–41) | 16 (8–44) | 0.795c |
| <5 years | 100 (13.2) | 55 (12.6) | 45 (13.8) | 0.785b |
| 5–14 years | 264 (34.7) | 153 (35.2) | 111 (34.2) | |
| 15–29 years | 134 (17.6) | 81 (18.6) | 53 (16.3) | |
| 30+ years | 262 (34.5) | 146 (33.6) | 116 (35.7) | |
BB, benzyl benzoate group; IVM, ivermectin group.
a
Includes six Indian–Fijian (all in Tailevu) and two European (one in Tailevu and one in Rewa).
b
Chi-squared test.
c
Wilcoxon rank-sum test.